Emergent BioSolutions (EBS) Amortization - Intangibles (2018 - 2026)

Emergent BioSolutions' Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $16.5 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles rose 1.23% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $65.3 million (changed 0.15% YoY), while the FY2025 annual figure was $65.1 million, changed 0.0% from the prior year.
• Amortization - Intangibles was $16.5 million for Q1 2026 at Emergent BioSolutions, up from $16.3 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $17.9 million in Q4 2022 to a low of $14.0 million in Q1 2022.
• Historically, Amortization - Intangibles has averaged $16.0 million across 5 years, with a median of $16.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles advanced 27.86% in 2022, then retreated 9.5% in 2023.
• A 5-year view of Amortization - Intangibles shows it stood at $17.9 million in 2022, then fell by 9.5% to $16.2 million in 2023, then rose by 0.62% to $16.3 million in 2024, then advanced by 0.0% to $16.3 million in 2025, then grew by 1.23% to $16.5 million in 2026.
• The last three Amortization - Intangibles figures came in at $16.5 million (Q1 2026), $16.3 million (Q4 2025), and $16.3 million (Q3 2025), per Business Quant data.